“Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis”, J of Skin, vol. 5, no. 6, p. s47, Nov. 2021, doi: 10.25251/skin.5.supp.47.